Kolexia
Lopez Anthony Gastro-entérologie
Lopez Anthony
Gastro-entérologie
Clinique Saint Andre
Vandoeuvre-lès-Nancy, France
131 Activités
41 Followers
Scientifique
Digital
Production scientifique
Activités par an
Expertise
Sujets de recherche
{{person.topmesh1.name}} Maladies inflammatoires intestinales Adénocarcinome Carcinomes Tumeurs du pancréas Tumeurs colorectales Rectocolite hémorragique Maladie de Crohn Tumeurs de l'oesophage Colite

Collaborateurs

Voir plus
Peyrin-Biroulet Laurent
Peyrin-Biroulet Laurent
Hôpital Brabois, Vandoeuvre-lès-Nancy, France
Bronowicki Jean Pierre
Bronowicki Jean Pierre
Hôpital Brabois, Vandoeuvre-lès-Nancy, France
Bensenane-Oussalah Mouni
Bensenane-Oussalah Mouni
Hôpital Brabois, Vandoeuvre-lès-Nancy, France
Lambert Aurelien
Lambert Aurelien
Institut de cancérologie de Lorraine, Vandoeuvre-lès-Nancy, France

Industries

Voir plus
Ipsen
10 collaboration(s)
Dernière en 2022
Vifor
8 collaboration(s)
Dernière en 2022
Bayer
8 collaboration(s)
Dernière en 2023
Servier
6 collaboration(s)
Dernière en 2023

Dernières activités

Voir plus
CAPANCOVID-19: Reorganization of the Healthcare System During COVID-19 Pandemic: Impact on Management of Patients With Exocrine Pancreatic Cancer
Essai Clinique (CHU Reims)   23 janvier 2024
Prediction of Adjuvant Gemcitabine Sensitivity in Resectable Pancreatic Adenocarcinoma Using the GemPred RNA Signature: An Ancillary Study of the PRODIGE-24/CCTG PA6 Clinical Trial.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology   14 novembre 2023
RHOM's Dr. Nicole Martin Is 'Feeling Good' After ... - Yahoo
Yahoo   06 novembre 2023
Personalized therapy based on image for esophageal or gastroesophageal junction adenocarcinoma.
Annals of translational medicine   05 novembre 2023
POCHI: Pembrolizumab in Combination With Xelox Bevacizumab in Patients With Microsatellite Stable Mestatic Colorectal Cancer and a High Immune Infiltrate : a Proof of Concept Study
Essai Clinique (Fédération Francophone de Cancérologie Digestive)   16 août 2023
Atezolizumab plus bevacizumab in advanced hepatocellular carcinoma after treatment failure with multikinase inhibitors.
Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver   03 avril 2023
Incidence and associated factors of cetuximab-induced hypersensitivity infusion reactions in 1392 cancer patients treated in four French areas: a possible association with Lyme disease?
BMC cancer   25 novembre 2022
Five-Year Outcomes of FOLFIRINOX vs Gemcitabine as Adjuvant Therapy for Pancreatic Cancer: A Randomized Clinical Trial.
JAMA oncology   21 novembre 2022
1297P Adjuvant gemcitabine is as efficient as mFOLFIRINOX in patients with GemPred+ tumor signature and resected pancreatic adenocarcinoma (PDAC): An ancillary study of the PRODIGE-24 clinical trial
Abstract Book of the ESMO Congress 2022, 9 - 13 September 2022   01 septembre 2022
Triggering Receptors Expressed on Myeloid Cells 1 : Our New Partner in Human Oncology?
Frontiers in oncology   08 juillet 2022